[HTML][HTML] Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
The rapid development of multiple vaccines providing strong protection from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …
[HTML][HTML] COVID-19 outcomes and risk factors among people living with HIV
MA Spinelli, BLH Jones, M Gandhi - Current HIV/AIDS Reports, 2022 - Springer
Abstract Purpose of Review In this review, we examine the intersection of the HIV and
COVID-19 epidemics with focus on COVID-19-related health outcomes and risk factors for …
COVID-19 epidemics with focus on COVID-19-related health outcomes and risk factors for …
Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with …
Abstract Background Data on SARS-CoV-2 vaccine immunogenicity in PLWH are currently
limited. Aim of the study was to investigate immunogenicity according to current CD4 T-cell …
limited. Aim of the study was to investigate immunogenicity according to current CD4 T-cell …
[HTML][HTML] Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in …
Background The risk of severe COVID-19 outcomes in people with immune-mediated
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …
[HTML][HTML] Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
ZL Brumme, F Mwimanzi, HR Lapointe, PK Cheung… - npj Vaccines, 2022 - nature.com
Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …
Assessment of clinical outcomes among children and adolescents hospitalized with COVID-19 in 6 sub-Saharan African countries
JB Nachega, NA Sam-Agudu, RN Machekano… - JAMA …, 2022 - jamanetwork.com
Importance Little is known about COVID-19 outcomes among children and adolescents in
sub-Saharan Africa, where preexisting comorbidities are prevalent. Objective To assess the …
sub-Saharan Africa, where preexisting comorbidities are prevalent. Objective To assess the …
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
LC Netto, KY Ibrahim, CM Picone, APPS Alves… - The Lancet …, 2022 - thelancet.com
Background People living with HIV might have a poor or delayed response to vaccines,
mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this …
mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this …
Analysis of severe illness after postvaccination COVID-19 breakthrough among adults with and without HIV in the US
R Lang, E Humes, SB Coburn, MA Horberg… - JAMA network …, 2022 - jamanetwork.com
Importance Understanding the severity of postvaccination SARS-CoV-2 (ie, COVID-19)
breakthrough illness among people with HIV (PWH) can inform vaccine guidelines and risk …
breakthrough illness among people with HIV (PWH) can inform vaccine guidelines and risk …
[HTML][HTML] Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised …
Background There is a paucity of data on COVID-19 vaccines in people living with HIV-1,
who could be at increased risk of severe illness and death from COVID-19. We evaluated …
who could be at increased risk of severe illness and death from COVID-19. We evaluated …
[HTML][HTML] COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review
Introduction Patients with immunodeficiency are usually more prone to worse outcomes of
infectious diseases. However, there are some disagreements in the context of COVID-19, for …
infectious diseases. However, there are some disagreements in the context of COVID-19, for …